US2013122582A1PendingUtilityA1

Expression vector

48
Assignee: ANAEROPHARMA SCIENCE INCPriority: Apr 17, 2008Filed: Jan 24, 2013Published: May 16, 2013
Est. expiryApr 17, 2028(~1.8 yrs left)· nominal 20-yr term from priority
A61P 9/00A61P 35/00A61P 43/00A61P 9/10A61K 31/7016C12N 15/74A61K 35/74C12N 15/746A61K 31/7004C12N 15/11
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A conventional shuttle vector constructed by fusing an E. coli -derived plasmid and a transformant-derived plasmid functions in both E. coli and the transformant bacterium, and there exists no expression vector that functions only in a non- E. coli transformant. The present invention provides an plasmid expression vector comprising (1) a plasmid replication unit that functions in an anaerobic microorganism other than E. coli and (2) a protein expression unit formed from DNA coding for a protein having target activity and a DNA fragment containing a promoter and a terminator that function in the anaerobic microorganism. The expression vector of the present invention is capable of being replicated only in a transformant, eliminating the risk of the replication of the transformant gene in other pathogenic or aerobic bacterium, providing an extremely safe and reliable vector and gene transporter for therapeutic application.

Claims

exact text as granted — not AI-modified
1 . An isolated expression vector that functions in an anaerobic microorganism, the expression vector not containing a plasmid replication unit that functions in  E. coli.    
     
     
         2 .- 42 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.